3-(4-Hydroxy-3-methoxyphenyl)-4-(4-(trifluoromethyl)phenyl)-1,2,4-triazoline-5-thione, 95%, 1g

Monoethyl Pimelate>98.0%(GC)5g

(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-((tert-butoxycarbonyl)amino)butanoic acid, 97%, 1g

Heparin sodium salt, min. 180 IU/mg, Ph.Eur., from porcine intestinal mucosa, 5 g

1-(Oxetan-3-yl)piperidin-4-ol, 98%, 100mg

1-(4-Trifluoromethylphenyl)-1,2-propanedione, 95.0%, 25g

3-Amino-N-(4-phenoxyphenyl)benzamide, 95.0%, 1g

3-fluoro-3'-morpholinomethyl benzophenone, 97.0%, 1g

4-Bromo-2-methyl-1-indanone>98.0%(GC)1g

1,3-Dioxolane (stabilized with BHT)>98.0%(GC)25mL

3,5-Dimethylisoxazole, 99.0%, 100g

N-(cyclopropylmethyl)-1-[7-(4-methylphenyl)-4-oxo-1H,4H-thieno[3,2-d]pyrimidin-2-yl]piperidine-3-carboxamide, 98%, 1mg

Ranitidine Hydrochloride>98.0%(HPLC)(T)25g